Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Benefits of wellness program for people with multiple sclerosis demonstrated in pilot study

  • Multiple sclerosis drug candidate shows new promise

  • Domestic violence likely more frequent for same-sex couples, review suggests

  • Fear of failure from a young age affects attitude to learning

  • Friend or foe: 'Devastating' number of hate-fuelled crimes are committed by friends, colleagues, carers of victims

  • Narrow focus on physical activity could be ruining kids' playtime

  • Putting dementia carers in control

  • Mechanism of Parkinson's spread demonstrated

  • Nerve cells: Communication without detours

  • Mothers of children with autism less likely to have taken iron supplements in pregnancy, study shows

  •